Source-linked briefing Health

Single-Dose Gene Therapy Cuts ‘Bad’ Cholesterol by 62% in Early Trial

Single-Dose Gene Therapy Cuts ‘Bad’ Cholesterol by 62% in Early Trial

An experimental gene therapy reduced participants’ bad cholesterol by about 62% after just one injection in a recent trial. Researchers hailed the result as an exciting milestone, though the approach remains under investigation.

Original headline

‘An extremely exciting milestone!’: landmark treatment slashes cholesterol by 62% with a single dose